Piramal Pharma Limited — Others, 21-01-2025: Giving guarantees/indemnity/ becoming a surety for third party

Piramal Pharma Limited has issued a corporate guarantee of up to USD 216 million (approximately ₹1,780 crore) for financing arrangements benefitting its wholly owned subsidiaries, Piramal Dutch Holdings N.V. and PPL Pharma Inc. This transaction, which involves multiple financial institutions, is being conducted on an arm's length basis, with no interest from the promoter group. Currently, this corporate guarantee presents a contingent liability for Piramal Pharma, but it is not expected to impact the company adversely. Investors may view this as a strategic move to strengthen financial positioning, contributing to a positive outlook on operational flexibility.